Manchester Hospital
Manchester, United Kingdom
Completed
NCT Number: NCT01097993
A Single-centre, Randomised, Double-blind, Controlled, Parallel-group Study to Evaluate the Effect of a Fermented Dairy Product on Abdominal Distension, Digestive Symptoms and Rectal Sensitivity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
The purpose of this study is to evaluate the effect of a commercially available fermented dairy product containing probiotics (4 weeks, twice a day) on abdominal distension in IBS patients with constipation (IBS-C).
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- female
- Age: 18-70
Exclusion criteria
- NA
Treatment and study plan
1-fermented dairy product
OtherArm 1 - Intervention 1 (probiotics)
2- milk-based non-fermented dairy product (control product)
OtherArm 2 - Intervention 2 (control)
Primary outcomes
-
Mean abdominal distension after a 4-week period of product consumption in IBS-C patients
Time frame: 0-4 weeks
Sponsors and collaborators
Lead sponsor
Danone Global Research & Innovation Center
Industry
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2012
- Study completion
- 2014
- First posted
- Apr 2, 2010
- Registry last updated
- Jan 20, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.